StockTipsArenaBeta

SELL Ajanta Pharma Limited — Elara Capital

SELLAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byElara CapitalHorizon: NA (inferred 1 year)2 Nov 2026via ET Now (Live)

Entry₹3,477.3Inferred
Target₹3,310
Total upside +4.81% (call closed)
Stop lossNot given
Exit₹3,3103 Nov 2026, 12:00 am
Target hit+4.81%0.00%upside left
Follow Elara Capital for new calls(100% target hit, 26 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 4 active Long-term calls on AJANTPHARMSee 542 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Nov 2026
3 supporting2 neutral10 opposing
Supports the SELL call (3)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix

NewsNdtv-Profit·2 Nov · today

(opens in new tab)

Pls find enclosed Financial Results for the quarter ended 30.09.2026.

BSE · Board Meeting·30 Oct · 3d ago

(opens in new tab)
Weighs against the SELL call (10)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·1 Nov · yesterday

Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

NewsCnbc-Tv18·30 Oct · 3d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Elara Capital

Every call and its outcome